Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - The page footer revision/version was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:34:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    First Hospital of China Medical University was added as a study site and First Affiliated Hospital of China Medical University was removed. The document revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:58:21.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:22:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:53.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-13T13:37:33.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Version bump from v3.4.0 to v3.4.1. No visible changes to the study details page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:21.000Z thumbnail image

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.